MarketResearch announces publication of its most recently generated research report titled, “Global In-vitro Diagnostics Instruments Market by product type, application, and region – Global Forecast to 2026”, which offers a holistic view of the global in-vitro diagnostics instruments market through systematic segmentation that covers every aspect of the target market. According to the forecast projections, revenue from the global in-vitro diagnostics instruments market is expected to expand at a moderate CAGR of 2.9%% during the forecast period.

According to in-vitro diagnostics instruments market infographics: Global In-vitro Diagnostics Instruments Market: Segmental Snapshot

The market report has been segmented on the basis of product type, end-user, and region. The product type segments include Immunochemistry, Clinical microbiology, POCT, SMBG, Tissue diagnostics, Molecular diagnostics, Hemostasis. End-user segments include the Hospitals and diagnostic laboratories, Home care, Academic and research institutes. The regions and countries covered in the analysis are North America, Europe, Asia Pacific, Latin America, and Rest of the World.

READ ALSO:  A Look At Professional Teeth Whitening

The global in-vitro diagnostics instruments market was valued at US$ 7,316.9 Mn in 2016 and is projected to reach US$ 13,881.5 Mn in 2026 at a CAGR of 6.6% from 2017 to 2026.

Key Players: Hoffmann-La Roche Ltd, Abbott Laboratories, Siemens AG, Danaher, Thermo Fisher Scientific Inc, Sysmex Corporation, Alere Inc, BioMerieux SA, Becton, Dickinson and Co

Global In-vitro Diagnostics Instruments Market Growth CAGR of 6.6% from 2017 to 2026.

Source of Infographics: In-vitro diagnostics instruments market Infographics by MarketResearch

Loading